Welcome to DrugBase!

Latest Drugs:

Latest Content:

Exondys 51 Injection Approved for Duchenne Muscular Dystrophy

Posted in: News Under: New Drugs On: September 19th, 2016

The FDA approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13% of the population with DMD.